After siCTCF treatment, Western blot revealed that the expression of CTCF, pFOXO1a and pFOXO3a was down‐regulated, while that of FOXO1a and FOXO3a was up‐regulated in tumour issues (Figure 6D). The gene discussed is FOXO3; the disease is neoplasm.